Matches in Wikidata for { <http://www.wikidata.org/entity/Q65384252> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q65384252 description "clinical trial" @default.
- Q65384252 description "ensayu clínicu" @default.
- Q65384252 description "klinisch onderzoek" @default.
- Q65384252 description "клінічне випробування" @default.
- Q65384252 name "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 name "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 type Item @default.
- Q65384252 label "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 label "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 prefLabel "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 prefLabel "A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy" @default.
- Q65384252 P1050 Q65384252-74BCD444-78DC-4895-B7CD-41B6CEC705AD @default.
- Q65384252 P1050 Q65384252-946294C5-F893-4CBE-B8CE-E48F6A63C3C8 @default.
- Q65384252 P1132 Q65384252-1F2D54FA-AF37-4E79-80D2-54ACFB38D855 @default.
- Q65384252 P1476 Q65384252-D289765F-FA7B-4208-AE97-E6B8686AC82C @default.
- Q65384252 P17 Q65384252-15178D6E-8D52-4846-B2C8-57A205C1183A @default.
- Q65384252 P17 Q65384252-27D9B888-2D73-4472-9F0E-851EFBB289C2 @default.
- Q65384252 P17 Q65384252-29C791DB-221E-432C-872D-8C21B63F96D4 @default.
- Q65384252 P17 Q65384252-2B0E7596-8AA8-4923-9869-C9AA56D3A943 @default.
- Q65384252 P17 Q65384252-3F750D35-D919-4279-B1B3-B6D15EE76FE1 @default.
- Q65384252 P17 Q65384252-414B6BAF-5D95-4ABE-9211-3300B60B0652 @default.
- Q65384252 P17 Q65384252-4BD7EEA4-E811-45CD-A6B5-2142E231BF23 @default.
- Q65384252 P17 Q65384252-5E017C45-46E8-49F4-9FA6-9DC402F2DF5D @default.
- Q65384252 P17 Q65384252-5F170F71-DB5F-40E0-8D5C-202C36A978D4 @default.
- Q65384252 P17 Q65384252-62AAF1F7-4416-46B9-B0A4-69E894A92179 @default.
- Q65384252 P17 Q65384252-8E7CE498-1D14-4371-A7F3-BF3DDC7C3CC4 @default.
- Q65384252 P17 Q65384252-8F2E885E-1BC4-49B3-AC66-ACC1FAB77FF2 @default.
- Q65384252 P17 Q65384252-94B79332-7594-4F11-9C04-7BEA7E40B221 @default.
- Q65384252 P17 Q65384252-B4DA4623-6CBE-49D0-8473-CBA199A09C02 @default.
- Q65384252 P17 Q65384252-B6D15F32-E9E3-4433-99F2-668B53F0258A @default.
- Q65384252 P17 Q65384252-DF14B0B3-E462-4D65-83C6-78AB675846B2 @default.
- Q65384252 P17 Q65384252-E7DA6CD6-C513-46A4-8D0E-5151B00D08F2 @default.
- Q65384252 P17 Q65384252-F1BF0E40-C9B1-4A5D-8FC9-4001B52D04E9 @default.
- Q65384252 P17 Q65384252-FD060871-10AC-4156-A775-A6266B319FCA @default.
- Q65384252 P17 Q65384252-FF4A11C3-E108-41AC-A8A9-91BC01AAA2CF @default.
- Q65384252 P2899 Q65384252-655691A9-4D41-4CF8-915E-DAAE78DB1C75 @default.
- Q65384252 P3098 Q65384252-B5ECBA43-203C-4338-A5CB-5C240E1FDFE4 @default.
- Q65384252 P31 Q65384252-5FAE22BC-A0C0-4D77-8A16-CD919FBA606F @default.
- Q65384252 P4844 Q65384252-68B9BD37-D987-4416-8C5F-4DB30669D4AE @default.
- Q65384252 P4844 Q65384252-871FC401-CC63-49CD-9149-D7A268827F73 @default.
- Q65384252 P4844 Q65384252-F39D7081-B08B-49CD-84DD-2F223C466969 @default.
- Q65384252 P580 Q65384252-51573453-E640-4ED1-AE7C-5A4611EA522B @default.
- Q65384252 P582 Q65384252-0B88C432-9921-4FE3-A7A4-6A6C6B55C8C7 @default.
- Q65384252 P6099 Q65384252-07996E4A-AB5F-4922-8CE9-D2470C69A9B0 @default.
- Q65384252 P6153 Q65384252-3D1D681C-50AF-4A38-9347-3D1578301908 @default.
- Q65384252 P8363 Q65384252-893836B5-0EA9-4E95-B6FD-3860C0BCEF3D @default.
- Q65384252 P859 Q65384252-3887BE45-5BDD-4C66-88E0-9875FF9550F6 @default.
- Q65384252 P1050 Q127076 @default.
- Q65384252 P1050 Q186889 @default.
- Q65384252 P1132 "+810" @default.
- Q65384252 P1476 "A Phase III Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group Study of the Efficacy and Safety of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist, Casopitant, Administered in Combination With ZOFRAN and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Subjects Receiving Highly Emetogenic Cisplatin-Based Chemotherapy" @default.
- Q65384252 P17 Q212 @default.
- Q65384252 P17 Q214 @default.
- Q65384252 P17 Q218 @default.
- Q65384252 P17 Q219 @default.
- Q65384252 P17 Q224 @default.
- Q65384252 P17 Q27 @default.
- Q65384252 P17 Q28 @default.
- Q65384252 P17 Q29 @default.
- Q65384252 P17 Q31 @default.
- Q65384252 P17 Q33 @default.
- Q65384252 P17 Q36 @default.
- Q65384252 P17 Q38 @default.
- Q65384252 P17 Q41 @default.
- Q65384252 P17 Q414 @default.
- Q65384252 P17 Q668 @default.
- Q65384252 P17 Q833 @default.
- Q65384252 P17 Q843 @default.
- Q65384252 P17 Q865 @default.
- Q65384252 P17 Q869 @default.
- Q65384252 P17 Q928 @default.
- Q65384252 P2899 "+18" @default.
- Q65384252 P3098 "NCT00431236" @default.
- Q65384252 P31 Q30612 @default.
- Q65384252 P4844 Q408524 @default.
- Q65384252 P4844 Q410011 @default.
- Q65384252 P4844 Q412415 @default.
- Q65384252 P580 "2006-11-06T00:00:00Z" @default.
- Q65384252 P582 "2007-10-09T00:00:00Z" @default.
- Q65384252 P6099 Q42824827 @default.
- Q65384252 P6153 Q212322 @default.
- Q65384252 P8363 Q78089383 @default.
- Q65384252 P859 Q212322 @default.